ONCOLOGY INSIGHTS

The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

ECCO 2018 11th European Breast Cancer Conference – Industry Highlights Katrina Mountfort, Senior Medical Writer, Touch Medical Media. Reading, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, Reading, UK
2017 – a Landmark Year for Food and Drug Administration Approvals for Haematological Malignancies Katrina Mountfort, Senior Medical Writer, Touch Medical Media, Reading, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, Reading, UK
Risk Stratification of Patients with Hormone-Receptor Positive Breast Cancer to Optimise Treatment Selection Peter Schmid
Professor of Cancer Medicine and Clinical Director of the St. Bartholomew Breast Cancer Centre, UK
Molecular Re-classification of Breast Cancer – Part 2 Joyce O’Shaughnessy
Chair, Breast Cancer Research, Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA
Molecular Re-classification of Breast Cancer – Part 1 Rebecca Dent
Senior Consultant in Medical Oncology, National Cancer Center, Singapore
Accreditation is key to focusing on quality and improvement Juliette Lobley, InHealth Communications Ltd, Ipswich, UK and Jagdeep Kudhail, East and North Hertfordshire NHS Trust, United Kingdom
Durvalumab: first immunotherapy to be approved for stage III non-small cell lung cancer Katrina Mountfort, Medical Writer, Touch Medical Media, Goring-on-Thames, UK
EANM FOCUS 1: The First Focus Meeting of the European Association of Nuclear Medicine Katrina Mountfort, Medical Writer, Touch Medical Media, Goring-on-Thames, UK
First-line Treatment Options for Renal Cell Carcinoma Ulka Vaishampayan, Oncology Multidisciplinary Team Chair and Associate Professor, Karmanos Cancer Institute, Wayne State University, Detroit, MI, US